Role of FDG-PET in the diagnosis and management of lung cancer
WJG Oyen, J Bussink, AFT Verhagen… - Expert review of …, 2004 - Taylor & Francis
Positron emission tomography (PET) using [18F]-2-deoxy-2-fluoro-d-glucose (FDG) has
emerged as a valuable diagnostic modality in patients with non-small cell lung cancer …
emerged as a valuable diagnostic modality in patients with non-small cell lung cancer …
PET/CT in non-small cell lung cancer staging—promises and problems
A Devaraj, GJR Cook, DM Hansell - Clinical radiology, 2007 - Elsevier
Integrated positron emission tomography/computed tomography (PET/CT) has many
advantages over solitary PET and CT, which has led it to become an increasingly …
advantages over solitary PET and CT, which has led it to become an increasingly …
The role of PET scan in diagnosis, staging, and management of non-small cell lung cancer
L Schrevens, N Lorent, C Dooms… - The oncologist, 2004 - academic.oup.com
Positron emission tomography (PET) is now an important cancer imaging tool, both for
diagnosis and staging, as well as offering prognostic information based on response. This …
diagnosis and staging, as well as offering prognostic information based on response. This …
[HTML][HTML] FDG-PET imaging in the management of non-small-cell lung cancer
E Salminen, M Mac Manus - Annals of oncology, 2002 - Elsevier
Lung cancer is currently the leading cause of cancer-related death in both men and women
in most Western countries. Tumour stage is the strongest prognostic factor and the most …
in most Western countries. Tumour stage is the strongest prognostic factor and the most …
Performance of integrated FDG-PET/CT for differentiating benign and malignant lung lesions-results from a large prospective clinical trial
S Pauls, AK Buck, G Halter, FM Mottaghy… - Molecular Imaging and …, 2008 - Springer
Purpose The purpose of the study was to evaluate prospectively whether integrated 2-deoxy-
2-[18 F] fluoro-d-glucose positron emission tomography/computed tomography (FDG …
2-[18 F] fluoro-d-glucose positron emission tomography/computed tomography (FDG …
Impact of FDG-labelled positron emission tomography imaging on the management of non-small-cell lung cancer
E Salminen, MM Manus - Annals of medicine, 2001 - Taylor & Francis
Lung cancer is currently the leading cause of cancer-related death in both men and women
in most Western countries. Although 5-year survival rates have doubled from 1960s they are …
in most Western countries. Although 5-year survival rates have doubled from 1960s they are …
The use of positron emission tomography (PET) in the staging/evaluation, treatment, and follow-up of patients with lung cancer: a critical review
M Mac Manus, RJ Hicks - … Journal of Radiation Oncology* Biology* Physics, 2008 - Elsevier
The availability of clinical positron emission tomography (PET) is increasing rapidly in the
developed world (1). This article reviews the role of PET scanning in lung cancer …
developed world (1). This article reviews the role of PET scanning in lung cancer …
PET scan in the staging of non-small cell lung cancer
JF Vansteenkiste - Lung cancer, 2003 - Elsevier
Imaging techniques play an essential role in the diagnosis, staging, and follow-up of patients
with lung cancer. Positron emission tomography (PET) has become an important innovation …
with lung cancer. Positron emission tomography (PET) has become an important innovation …
FDG-PET in staging lung cancer: how does it change the algorithm?
AFT Verhagen, GP Bootsma, VCG Tjan-Heijnen… - Lung cancer, 2004 - Elsevier
Background: In patients with lung cancer, positron emission tomography (PET) using fluor-
18-fluorodesoxyglucose (FDG) may be used both to detect extrathoracic metastases (ETM) …
18-fluorodesoxyglucose (FDG) may be used both to detect extrathoracic metastases (ETM) …
[HTML][HTML] PET/CT for staging lung cancer: costly or cost-saving?
Integrated functional and anatomical imaging using positron emission tomography (PET)/CT
hybrid scanners has changed the diagnostic algorithm in non-small cell lung cancer …
hybrid scanners has changed the diagnostic algorithm in non-small cell lung cancer …